Cargando…
Leadership for success in transforming medical abortion policy in Canada
OBJECTIVES: Mifepristone was approved for use in medical abortion by Health Canada in 2015. Approval was accompanied by regulations that prohibited pharmacist dispensing of the medication. Reproductive health advocates in Canada recognized this regulation would limit access to medical abortion and s...
Autores principales: | Dineley, Brigid, Munro, Sarah, Norman, Wendy V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948737/ https://www.ncbi.nlm.nih.gov/pubmed/31914156 http://dx.doi.org/10.1371/journal.pone.0227216 |
Ejemplares similares
-
Dispensing mifepristone for medical abortion in Canada: Pharmacists’ experiences of the first year
por: Zusman, Enav Z., et al.
Publicado: (2023) -
Pharmacist direct dispensing of mifepristone for medication abortion in Canada: a survey of community pharmacists
por: Zusman, Enav Z, et al.
Publicado: (2022) -
Barriers and enablers to nurse practitioner implementation of medication abortion in Canada: A qualitative study
por: Carson, Andrea, et al.
Publicado: (2023) -
Implementation of mifepristone medical abortion in Canada: pilot and feasibility testing of a survey to assess facilitators and barriers
por: Devane, Courtney, et al.
Publicado: (2019) -
First trimester medication abortion practice in the United States and Canada
por: Jones, Heidi E., et al.
Publicado: (2017)